CoChat

Three dimensional in vitro models of cancer: Bioprinting multilineage glioblastoma models

Open access
Hermida, Miguel A., Kumar, Jothi Dinesh, Schwarz, Daniela, Laverty, Keith G., Di Bartolo, Alberto, Ardron, Marcus, Bogomolnijs, Mihails, Clavreul, Anne, Brennan, Paul M., Wiegand, Ulrich K., Melchels, Ferry PW., Shu, Will, Leslie, Nicholas R. · 2020 · Advances in Biological Regulation
Cited by 105

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Three dimensional (3D) bioprinting of multiple cell types within optimised extracellular matrices has the potential to more closely model the 3D environment of human physiology and disease than current alternatives. In this study, we used a multi-nozzle extrusion bioprinter to establish models of glioblastoma made up of cancer and stromal cells printed within matrices comprised of alginate modified with RGDS cell adhesion peptides, hyaluronic acid and collagen-1. Methods were developed using U87MG glioblastoma cells and MM6 monocyte/macrophages, whilst more disease relevant constructs contained glioblastoma stem cells (GSCs), co-printed with glioma associated stromal cells (GASCs) and microglia. Printing parameters were optimised to promote cell-cell interaction, avoiding the 'caging in' of cells due to overly dense cross-linking. Such printing had a negligible effect on cell viability, and cells retained robust metabolic activity and proliferation. Alginate gels allowed the rapid recovery of printed cell protein and RNA, and fluorescent reporters provided analysis of protein kinase activation at the single cell level within printed constructs. GSCs showed more resistance to chemotherapeutic drugs in 3D printed tumour constructs compared to 2D monolayer cultures, reflecting the clinical situation. In summary, a novel 3D bioprinting strategy is developed which allows control over the spatial organisation of tumour constructs for pre-clinical drug sensitivity testing and studies of the tumour microenvironment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jbior.2019.100658

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 105

Metadata

Authors
Hermida, M. A., Kumar, J. D., Schwarz, D., Laverty, K. G., Di Bartolo, A., Ardron, M., Bogomolnijs, M., Clavreul, A., Brennan, P. M., Wiegand, U. K., Melchels, F. P., Shu, W., & Leslie, N. R.
Venue
Advances in Biological Regulation
Publisher
Elsevier BV
Published
2020-01
Volume
75
Pages
100658
ISSN
2212-4926 (ISSN-L)
OpenAlex
W2980654228
Cited by
105
References
19
FWCI
4.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Three dimensional in vitro models of cancer: Bioprinting multilineage glioblastoma models. https://app.cochat.ai/papers/10.1016/j.jbior.2019.100658
The paper
Hermida, M. A., Kumar, J. D., Schwarz, D., Laverty, K. G., Di Bartolo, A., Ardron, M., Bogomolnijs, M., Clavreul, A., Brennan, P. M., Wiegand, U. K., Melchels, F. P., Shu, W., & Leslie, N. R. (2020). Three dimensional in vitro models of cancer: Bioprinting multilineage glioblastoma models. Advances in Biological Regulation. https://doi.org/10.1016/j.jbior.2019.100658

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.